Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 18;11(1):e002526.
doi: 10.1136/openhrt-2023-002526.

Association of HFA-PEFF score with clinical outcomes after catheter ablation for atrial fibrillation

Taiji Okada  1 , Takeshi Kitai  2 , Atsushi Kobori  3 , Madoka Sano  4 , Ryosuke Murai  4 , Toshiaki Toyota  4 , Yasuhiro Sasaki  4 , Tomohiko Taniguchi  5   6 , Kitae Kim  4 , Natsuhiko Ehara  3 , Makoto Kinoshita  4 , Yutaka Furukawa  4
Affiliations

Association of HFA-PEFF score with clinical outcomes after catheter ablation for atrial fibrillation

Taiji Okada et al. Open Heart. .

Abstract

Background: The Heart Failure Association Pretest assessment, echocardiography and natriuretic peptide, functional testing and final aetiology (HFA-PEFF) score has been developed for diagnosing heart failure with preserved ejection fraction (HFpEF), which is frequently associated with atrial fibrillation (AF). We aimed to investigate whether preprocedural HFA-PEFF score could be used to predict clinical outcomes in patients with AF who underwent catheter ablation (CA).

Methods: Overall, 1679 patients with AF who underwent primary CA (71±10 years, 1218 males (72.5%), median follow-up duration 3.3 years) from July 2011 to December 2019 were included in this retrospective study. HFpEF was defined as an HFA-PEFF score ≥5. The primary study outcome was 5-year major adverse cardiovascular and cerebrovascular events (MACCE), which is a composite of all-cause death, hospitalisation for heart failure (HF) and hospitalisation for stroke.

Results: The prevalence of HFpEF was 32.3%, but only 7.7% were diagnosed with HF at the time of CHADS2 scoring. Five-year MACCE occurred in 77 patients (4.6%). The cumulative 5-year incidence of MACCE was significantly higher in the HFpEF group than in the non-HFpEF group (11.2% vs 4.8% at 5 years, p<0.001). In the multivariable analysis, HFpEF by the HFA-PEFF score was associated with MACCE (adjusted HR 1.65, 95% CI 1.02 to 2.65, p=0.041).

Conclusions: Early detection of HFpEF using the HFA-PEFF score may have clinical applications in guiding therapeutic decision-making and improving prognosis by preventing HF and stroke in patients with AF undergoing CA.

Keywords: atrial fibrillation; catheter ablation; heart failure, diastolic.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Flow chart illustrating the study population. Overall, 2123 patients with AF who underwent primary ablation were screened, and finally, 1679 patients were analysed retrospectively in this study. The circles in the diagram represent the percentage of heart failure with preserved left ventricular ejection fraction at each score. AF, atrial fibrillation; HFA-PEFF, Heart Failure Association Pretest assessment, echocardiography and natriuretic peptide, functional testing and final aetiology; HFpEF, heart failure preserved left ventricular ejection fraction; LVEF, left ventricular ejection fraction.
Figure 2
Figure 2
Kaplan-Meier analyses show the cumulative rate of the primary composite end point (A), all-cause death (B), hospitalisation for HF (C) and hospitalisation for stroke (D) stratified by the Heart Failure Association Pretest assessment, echocardiography and natriuretic peptide, functional testing and final aetiology score. HFpEF, heart failure preserved left ventricular ejection fraction.
Figure 3
Figure 3
Kaplan-Meier analyses show the cumulative rate of the primary composite end point stratified by the HFA-PEFF score in the subgroup of patients with paroxysmal AF (A), persistent AF (B), AF recurrence (C) and AF no recurrence (D). AF, atrial fibrillation; HFA-PEFF, Heart Failure Association Pretest assessment, echocardiography and natriuretic peptide, functional testing and final aetiology; HFpEF, heart failure preserved left ventricular ejection fraction.
See this image and copyright information in PMC

References

    1. Vermond RA, Geelhoed B, Verweij N, et al. . Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: A community-based study from the Netherlands. J Am Coll Cardiol 2015;66:1000–7. 10.1016/j.jacc.2015.06.1314 - DOI - PubMed
    1. Zafrir B, Lund LH, Laroche C, et al. . Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European society of cardiology heart failure long-term Registry. Eur Heart J 2018;39:4277–84. 10.1093/eurheartj/ehy626 - DOI - PubMed
    1. McDonagh TA, Metra M, Adamo M, et al. . 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) with the special contribution of the heart failure Association (Hfa) of the ESC. Rev Esp Cardiol (Engl Ed) 2022;75:523. 10.1016/j.rec.2022.05.005 - DOI - PubMed
    1. Bozkurt B, Coats AJ, Tsutsui H, et al. . Universal definition and classification of heart failure: A report of the heart failure society of America, heart failure Association of the European society of cardiology, Japanese heart failure society and writing committee of the universal definition of heart failure. J Card Fail 2021:00050–6. 10.1016/j.cardfail.2021.01.022 - DOI
    1. Reddy YNV, Carter RE, Obokata M, et al. . A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation 2018;138:861–70. 10.1161/CIRCULATIONAHA.118.034646 - DOI - PMC - PubMed